|Share this content:|
|Home||About Us||Our Attorneys||Cases||Practice Areas||Settlement Notices||News & Events||Contact Us|
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In BioScrip, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in BioScrip, Inc. (“BioScrip” or the “Company”) (NASDAQ: BIOS) of the November 29, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against BioScrip and certain executives.
A complaint has been filed on behalf of all persons who purchased BioScrip securities between August 8, 2011 and September 20, 2013 (the “Class Period”).
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that BioScrip issued false and/or misleading statements concerning (i) the improper distribution of its product Exjade through its specialty pharmacy division and (ii) the violation of certain federal and state laws and regulations.
On September 23, 2013, the Company announced that the U.S. Attorney’s Office for the Southern District of New York issued a civil investigative demand and the New York State Attorney General’s Medicaid Fraud Control Unit issued a subpoena regarding the distribution of Exjade by BioScrip’s specialty pharmacy division.
Following this news, the Company’s stock declined $2.60 per share or 23% within two trading sessions, to close at $8.47 per share on September 24, 2013.
If you invested in BioScrip stock or options between August 8, 2011 and September 20, 2013 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding BioScrip’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.